A carregar...
Mechanisms of resistance and sensitivity to anti-HER2 therapies in HER2+ breast cancer
Breast Cancer (BC) is a highly prevalent disease. A woman living in the United States has a 12.3% lifetime risk of being diagnosed with breast cancer [1]. It is the most common female cancer and the second most common cause of cancer death in women [2]. Of note, amplification or overexpression of Hu...
Na minha lista:
| Publicado no: | Oncotarget |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Impact Journals LLC
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5325455/ https://ncbi.nlm.nih.gov/pubmed/26824988 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.7043 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|